These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 2548413
1. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease]. Radikov N. Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413 [Abstract] [Full Text] [Related]
2. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases]. Zhang WY. Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204 [Abstract] [Full Text] [Related]
3. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases. Zhang WY, Yen GL. Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674 [Abstract] [Full Text] [Related]
4. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin. Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G. Oncodev Biol Med; 1982 Dec; 3(4):315-23. PubMed ID: 6291007 [Abstract] [Full Text] [Related]
5. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease. Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC. Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088 [Abstract] [Full Text] [Related]
7. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein. O'Brien TJ, Engvall E, Schlaerth JB, Morrow CP. Am J Obstet Gynecol; 1980 Oct 01; 138(3):313-20. PubMed ID: 6251725 [Abstract] [Full Text] [Related]
8. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Kohorn EI. Gynecol Oncol; 2002 May 01; 85(2):315-20. PubMed ID: 11972394 [Abstract] [Full Text] [Related]
9. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM. Gynecol Oncol; 2007 Jul 01; 106(1):142-6. PubMed ID: 17462723 [Abstract] [Full Text] [Related]
10. [Trophoblastic beta 1-glycoprotein in the blood in trophoblastic tumors]. Sokolov AV, Zhordaniia KI, Ledian KM. Med Radiol (Mosk); 1983 Aug 01; 28(8):25-31. PubMed ID: 6310307 [Abstract] [Full Text] [Related]
11. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases. Than GN, Bohn H, Csaba IF, Szabó DG, Karg NJ, Göcze P. Arch Gynecol; 1981 Aug 01; 231(1):33-9. PubMed ID: 6174083 [Abstract] [Full Text] [Related]
12. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence. Szymendera JJ, Ploch E, Zalucka K, Sikorowa L, Kaminska JA, Gadek A. Gynecol Oncol; 1986 Feb 01; 23(2):149-59. PubMed ID: 3002918 [Abstract] [Full Text] [Related]
13. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease. Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K. Gynecol Obstet Invest; 1987 Feb 01; 23(3):151-6. PubMed ID: 3036671 [Abstract] [Full Text] [Related]
14. Concanavalin A binding of pregnancy-specific beta-1-glycoprotein in normal pregnancy and trophoblastic disease. Koistinen R, Heikinheimo M, Rutanen EM, Stenman UH, Lee JN, Seppälä M. Oncodev Biol Med; 1981 Feb 01; 2(3):179-82. PubMed ID: 6272237 [Abstract] [Full Text] [Related]
15. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio. Sakuragi N. Gynecol Oncol; 1982 Jun 01; 13(3):393-8. PubMed ID: 6178652 [No Abstract] [Full Text] [Related]